RAPP
Rapport Therapeutics Inc

388
Mkt Cap
$1.28B
Volume
231,386.00
52W High
$42.27
52W Low
$6.43
PE Ratio
-10.00
RAPP Fundamentals
Price
$26.93
Prev Close
$27.92
Open
$27.82
50D MA
$28.26
Beta
1.43
Avg. Volume
408,088.23
EPS (Annual)
-$2.14
P/B
2.51
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Rapport Therapeutics (NASDAQ:RAPP) Upgraded to Hold at Wall Street Zen
Wall Street Zen raised Rapport Therapeutics from a "sell" rating to a "hold" rating in a research note on Sunday...
MarketBeat·17h ago
News Placeholder
More News
News Placeholder
Abraham Ceesay Sells 5,833 Shares of Rapport Therapeutics (NASDAQ:RAPP) Stock
Rapport Therapeutics, Inc. (NASDAQ:RAPP - Get Free Report) CEO Abraham Ceesay sold 5,833 shares of Rapport Therapeutics stock in a transaction that occurred on Tuesday, January 20th. The stock was...
MarketBeat·3d ago
News Placeholder
Rapport Therapeutics, Inc. (NASDAQ:RAPP) Short Interest Up 20.7% in December
Rapport Therapeutics, Inc. (NASDAQ:RAPP - Get Free Report) was the recipient of a large increase in short interest in December. As of December 31st, there was short interest totaling 2,692,137...
MarketBeat·6d ago
News Placeholder
Rapport Therapeutics, Inc. (NASDAQ:RAPP) Given Average Rating of "Moderate Buy" by Analysts
Shares of Rapport Therapeutics, Inc. (NASDAQ:RAPP - Get Free Report) have earned an average recommendation of "Moderate Buy" from the eight analysts that are presently covering the firm, Marketbeat...
MarketBeat·7d ago
News Placeholder
Rapport Therapeutics (NASDAQ:RAPP) Downgraded by Wall Street Zen to "Sell"
Wall Street Zen lowered Rapport Therapeutics from a "hold" rating to a "sell" rating in a report on Saturday...
MarketBeat·9d ago
News Placeholder
Rapport Therapeutics (NASDAQ:RAPP) Insider David Bredt Sells 8,500 Shares
Rapport Therapeutics, Inc. (NASDAQ:RAPP - Get Free Report) insider David Bredt sold 8,500 shares of the stock in a transaction that occurred on Thursday, January 15th. The shares were sold at an...
MarketBeat·9d ago
News Placeholder
Rapport Therapeutics (NASDAQ:RAPP) Trading Down 6.9% - Time to Sell?
Rapport Therapeutics (NASDAQ:RAPP) Stock Price Down 6.9% - What's Next...
MarketBeat·13d ago
News Placeholder
Insider Selling: Rapport Therapeutics (NASDAQ:RAPP) Insider Sells 2,840 Shares of Stock
Rapport Therapeutics, Inc. (NASDAQ:RAPP - Get Free Report) insider Krishnaswamy Yeleswaram sold 2,840 shares of Rapport Therapeutics stock in a transaction on Wednesday, December 31st. The shares...
MarketBeat·20d ago
News Placeholder
Krishnaswamy Yeleswaram Sells 2,840 Shares of Rapport Therapeutics (NASDAQ:RAPP) Stock
Rapport Therapeutics, Inc. (NASDAQ:RAPP - Get Free Report) insider Krishnaswamy Yeleswaram sold 2,840 shares of the firm's stock in a transaction dated Wednesday, December 31st. The shares were sold...
MarketBeat·20d ago
News Placeholder
Rapport Therapeutics (NASDAQ:RAPP) Insider Sells $197,338.35 in Stock
Rapport Therapeutics, Inc. (NASDAQ:RAPP - Get Free Report) insider David Bredt sold 6,567 shares of the business's stock in a transaction on Wednesday, December 31st. The stock was sold at an average...
MarketBeat·20d ago
<
1
2
...
>

Latest RAPP News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.